gsk boston - Search News

News

GSK buys liver drug from Boston Pharmaceuticals

GSK buys liver drug from Boston Pharmaceuticals for up to $2 billion

GSK is acquiring an experimental medicine from a Cambridge biotech to shore up its drug pipeline and muscle into the promising field of liver therapies.

· 7h

PharmExec · 13h

GSK Acquires Boston Pharmaceuticals’ Novel FGF21 Analog for Steatotic Liver Disease

· 15h · on MSN

GSK to buy liver disease drug for up to $2 billion

Pharmabiz1h

GSK to buy Boston Pharma’s efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of SLD

GSK to buy Boston Pharma’s efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of SLD: London, UK Thursday, May 15, 2025, ...

GSK to buy efimosfermin for up to $2 billion

GSK will buy efimosfermin, a specialty medicine used to treat liver disease from Boston Pharmaceuticals, for up to $2 billion ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

GSK buys liver drug from Boston Pharmaceuticals

Trending now